Signatures	Published year	Journal	Title	PMID	DOI
CD_8_T_effector	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
DDR	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
APM	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
Immune_Checkpoint	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
CellCycle_Reg	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
Pan_F_TBRs	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
Histones	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
EMT1	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
EMT2	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
EMT3	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
WNT_target	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
FGFR3_related	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
Cell_cycle	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
Mismatch_Repair	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
Homologous_recombination	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
Nucleotide_excision_repair	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
DNA_replication	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
Base_excision_repair	2018	Nature	TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	29443960	10.1038/nature25501
TMEscoreA_CIR	2019	Cancer Immunology Research	Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures	30842092	10.1158/2326-6066.CIR-18-0436
TMEscoreB_CIR	2019	Cancer Immunology Research	Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures	30842092	10.1158/2326-6066.CIR-18-0436
CD8_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
B_cells_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Treg_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Macrophages_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Neutrophils_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
NK_cells_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
pDCs_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
MHC_Class_I_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Co_stimulation_APC_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Co_stimulation_T_cell_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Co_inhibition_APC_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Co_inhibition_T_cell_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Type_I_IFN_Reponse_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Type_II_IFN_Reponse_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
Cytolytic_Activity_Rooney_et_al	2015	Cell	Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	25594174	10.1016/j.cell.2014.12.033
T_cell_inflamed_GEP_Ayers_et_al	2017	The Journal of Clinical Investigation	IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade	28650338	10.1172/JCI91190
IFNG_signature_Ayers_et_al	2017	The Journal of Clinical Investigation	IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade	28650338	10.1172/JCI91190
MDSC_Wang_et_al	2016	Canccer Discovery	Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression	26701088	10.1158/2159-8290.CD-15-0224
GPAGs	2017	Nature	Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming	28371798	10.1038/nature21724
PPAGs	2017	Nature	Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming	28371798	10.1038/nature21724
B_cells_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
CD45_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
CD8_T_cells_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
Cytotoxic_cells_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
DC_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
Exhausted_CD8_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
Macrophages_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
Mast_cells_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
Neutrophils_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
NK_CD56dim_cells_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
NK_cells_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
T_cells_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
Th1_cells_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
Treg_Danaher_et_al	2017	Journal for ImmunoTherapy of Cancer	Gene expression markers of Tumor Infiltrating Leukocytes	28239471	10.1186/s40425-017-0215-8
Nature_metabolism_Hypoxia	2019	Nature Metabolism	Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy	31984309	10.1038/s42255-019-0045-8
Winter_hypoxia_signature	2007	Cancer Research	Relation of a Hypoxia Metagene Derived From Head and Neck Cancer to Prognosis of Multiple Cancers	17409455	10.1158/0008-5472.CAN-06-3322
Hu_hypoxia_signature	2019	Molecular Biology and Evolution	The Genome Landscape of Tibetan Sheep Reveals Adaptive Introgression From Argali and the History of Early Human Settlements on the Qinghai-Tibetan Plateau	30445533	10.1093/molbev/msy208
MT_exosome	2019	Molecular Therapy. Nucleic Acids	An EV-Associated Gene Signature Correlates with Hypoxic Microenvironment and Predicts Recurrence in Lung Adenocarcinoma	31473584	10.1016/j.omtn.2019.07.021
SR_exosome	2017	Scientific Reports	Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer	28383029	10.1038/srep46102
EV_Cell_2020	2020	Cell	Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.	32795414	10.1016/j.cell.2020.07.009
MC_Review_Exosome1	2016	Molcular Cancer	Diagnostic, Prognostic and Predictive Value of Cell-Free miRNAs in Prostate Cancer: A Systematic Review	27189160	10.1186/s12943-016-0523-5
MC_Review_Exosome2	2016	Molcular Cancer	Clinical Relevance of Circulating Cell-Free microRNAs in Ovarian Cancer	27343009	10.1186/s12943-016-0536-0
CMLS_Review_Exosome	2018	Cellular and Molecular Life Sciences	Current knowledge on exosome biogenesis and release	28733901	10.1007/s00018-017-2595-9
Positive_regulation_of_exosomal_secretion	2020	Gene Ontology	http://geneontology.org/	NA	NA
Negative_regulation_of_exosomal_secretion	2020	Gene Ontology	http://geneontology.org/	NA	NA
Exosomal_secretion	2020	Gene Ontology	http://geneontology.org/	NA	NA
Exosome_assembly	2020	Gene Ontology	http://geneontology.org/	NA	NA
Extracellular_vesicle_biogenesis	2020	Gene Ontology	http://geneontology.org/	NA	NA
Molecular_Cancer_m6A	2020	Molecular Cancer	m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer	32164750	10.1186/s12943-020-01170-0
Ferroptosis	2020	IOBR	Constructed by IOBR organization after consulting literatures	NA	NA
MHC_Class_II	2020	IOBR	Constructed by IOBR organization after consulting literatures	NA	NA
MHC_Class_I	2020	IOBR	Constructed by IOBR organization after consulting literatures	NA	NA
HLA_signature_gene	2020	IOBR	Constructed by IOBR organization after consulting literatures	NA	NA
T_cell_accumulation_Peng_et_al	2018	Nature Medicine	Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response	30127393	10.1038/s41591-018-0136-1
T_cell_exhaustion_Peng_et_al	2018	Nature Medicine	Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response	30127393	10.1038/s41591-018-0136-1
T_cell_regulatory_Peng_et_al	2018	Nature Medicine	Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response	30127393	10.1038/s41591-018-0136-1
ICB_resistance_Peng_et_al	2018	Nature Medicine	Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response	30127393	10.1038/s41591-018-0136-1
MDSC_Peng_et_al	2018	Nature Medicine	Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response	30127393	10.1038/s41591-018-0136-1
TAM_Peng_et_al	2018	Nature Medicine	Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response	30127393	10.1038/s41591-018-0136-1
CAF_Peng_et_al	2018	Nature Medicine	Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response	30127393	10.1038/s41591-018-0136-1
Antigen_Processing_and_Presentation_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Antimicrobials_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
BCR_Signaling_Pathway_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Chemokines_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Chemokine_Receptors_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Cytokines_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Cytokine_Receptors_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Interferons_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Interferon_Receptor_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Interleukins_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Interleukins_Receptor_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
Natural_Killer_Cell_Cytotoxicity_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
TCR_signaling_Pathway_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
TGFb_Family_Member_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
TGFb_Family_Member_Receptor_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
TNF_Family_Members_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
TNF_Family_Members_Receptors_Li_et_al	2020	Nature Communication	Pan-cancer Characterization of Immune-Related lncRNAs Identifies Potential Oncogenic Biomarkers	32081859	10.1038/s41467-020-14802-2
CD8_T_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Tgd_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Cytotoxic_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
NK_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
NK_CD56dim_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
DC_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
iDC_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
aDC_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
pDC_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Eosinophils_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Macrophages_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Mast_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Neutrophils_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
SW480_cancer_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Normal_mucosa_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Blood_vessels_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Lymph_vessels_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
B_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
T_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
T_helper_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Tcm_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Tem_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Th1_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Th2_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Th17_cells_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
Treg_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
TFH_Bindea_et_al	2013	Immunity	Spatio-temporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer	24138885	10.1016/j.immuni.2013.10.003
T_cell_probe_Jeschke_et_al	2017	The Journal of Clinical Investigation	DNA Methylation-Based Immune Response Signature Improves Patient Diagnosis in Multiple Cancers	28714863	10.1172/JCI91095
MeTIL_Jeschke_et_al	2017	The Journal of Clinical Investigation	DNA Methylation-Based Immune Response Signature Improves Patient Diagnosis in Multiple Cancers	28714863	10.1172/JCI91095
TIP_Release_of_cancer_cell_antigens	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Cancer_antigen_presentation_1	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Cancer_antigen_presentation_2	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Priming_and_activation_1	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Priming_and_activation_2	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Trafficking_of_immune_cells_to_tumors	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Infiltration_of_immune_cells_into_tumors_1	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Infiltration_of_immune_cells_into_tumors_2	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Recognition_of_cancer_cells_by_T_cells_1	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Recognition_of_cancer_cells_by_T_cells_2	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Killing_of_cancer_cells_1	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TIP_Killing_of_cancer_cells_2	2018	Cancer Research	TIP: A Web Server for Resolving Tumor Immunophenotype Profiling	30154154	10.1158/0008-5472.CAN-18-0689
TLS_Nature	2020	Nature	Tertiary lymphoid structures improve immunotherapy and survival in melanoma	31942071	10.1038/s41586-019-1914-8
TMEscoreA_plus	2021	Journal for ImmunoTherapy of Cancer	Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer	34376552	10.1136/jitc-2021-002467
TMEscoreB_plus	2021	Journal for ImmunoTherapy of Cancer	Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer	34376552	10.1136/jitc-2021-002467
Cardiolipin_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Cardiolipin_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Cholesterol_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Citric_Acid_Cycle	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Cyclooxygenase_Arachidonic_Acid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Prostaglandin_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Purine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Pyrimidine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Dopamine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Epinephrine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Norepinephrine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Fatty_Acid_Degradation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Fatty_Acid_Elongation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Fatty_Acid_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Folate_One_Carbon_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Folate_biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Gluconeogenesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycolysis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycogen_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycogen_Degradation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Heme_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Hexosamine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Homocysteine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Remethylation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Transsulfuration	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Ketone_Biosynthesis_and_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Kynurenine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Methionine_Cycle	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Pentose_Phosphate	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Nicotinamide_Adenine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
ADP_Ribosylation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Nicotinamide_Adenine_Dinucleotide_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Nicotinate_and_Nicotinamide_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Sirtuin_Nicotinamide_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Polyamine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Prostanoid_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Thromboxane_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Pyruvate_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Retinoic_Acid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Retinoid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Retinol_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Steroid_Hormone_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Aldosterone_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Cortisol_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Estradiol_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Testosterone_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Urea_Cycle	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Vitamin_K	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Pentose_and_Glucuronate_Interconversions	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Fructose_and_Mannose_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Galactose_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Ascorbate_and_Aldrate_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Starch_and_Suctose_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Amino_Sugar_and_Nucleotide_Sugar_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glyoxylate_and_Dicarboxylate_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Propanoate_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Butanoate_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Inositol_Phosphate_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Oxidative_Phosphorylation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Nitrogen_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Sulfur_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Steroid_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Primary_Bile_Acid_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Steroid_Hormone_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycerolipid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycerophospholipid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Ether_Lipid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Shingolipid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Arachidonic_Acid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Linoleic_Acid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
alpha_Linoleic_Acid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Biosynthesis_of_Unsaturated_Fatty_Acids	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Purine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Pyrimidine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Alanine_Aspartate_and_Glutamate_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycine_Serine_and_Threonine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Cysteine_and_Methionine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Valine_Leucine_and_Isoleucine_Degradation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Valine_Leucine_and_Isoleucine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Lysine_Degradation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Arginine_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Arginine_and_Proline_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Histidine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Tyrosine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Phenylalanine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Tryptophan_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Phenylalanine_Tyrosine_and_Tryptophan_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Beta_Alanine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Taurine_and_Hypotaurine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Selenocompound_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
D_Glutamine_and_D_Glutamate_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glutathione_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
N_Glycan_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Mucin_Type_O_Glycan_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Other_Types_of_O_Glycan_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycosaminoglycan_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycosaminoglycan_Degradation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycosphosphatidylinositol	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Glycosphingolipid_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Other_Glycan_Degradation	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Thiamine_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Riboflavin_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Vitamin_B6_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Pantothenate_and_CoA_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Biotin_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Lipoic_Acid_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Porphyrin_and_Chlorophyll_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Ubiquinone_and_other_Terpenoid_Quinone_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Terpenoid_Backbone_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Caffiene_Metabolism	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Neomycin_Kanamysin_and_Gentamicin_Biosynthesis	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Metabolism_of_Xenobiotics_by_Cytochrome_P450	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Drug_Metabolism_by_Cytochrome_P450	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
Drug_Metabolism_by_other_enzymes	2018	Nature Communication	Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas	30552315	10.1038/s41467-018-07232-8
CD4_c0_Tcm	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c1_Treg	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c10_Tn_LEF1_ANKRD55	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c11_Tisg	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c2_Tn	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c3_Tfh	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c4_Tstr	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c5_CTL	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c6_Tn_FHIT	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c7_Tn_TCEA3	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c8_Tf17	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD4_c9_Tn_TCF7_SLC40A1	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c0_t_Teff	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c1_Tex	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c10_Teff_CD244	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c11_Teff_SEMA4A	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c12_Trm	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c13_Tn_TCF7	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c2_Teff	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c3_Tn	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c4_Tstr	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c5_Tisg	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c6_Tcm	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c7_p_Tex	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c8_Teff_KLRG1	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
CD8_c9_Tsen	2023	Nature Medicine	Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance	37248301	10.1038/s41591-023-02371-y
Mast	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mo_01_CD14	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mo_02_CD16	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mono_like_01_CD14	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mono_like_02_CD16	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mono_like_03_CD14CD16	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
MonoDC	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_01_MARCO	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_02_CCL20	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_03_SPP1	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_04_TREM2	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_05_IL1B	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_06_CXCL9	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_07_SLC40A1	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_08_APOE	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Mph_09_STMN1	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_01_MMP8	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_02_S100A12	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_03_ISG15	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_04_TXNIP	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_05_ELL2	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_06_PTGS2	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_07_APOA2	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_08_CD74	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_09_IFIT1	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_10_SPP1	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
Neu_11_CCL4	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
DC_01_CLEC9A	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
DC_02_CD1C	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
DC_03_LAMP3	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
DC_04_CD207	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
DC_05_LILRA4	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
DC_06_STMN1	2022	Nature	Liver tumour immune microenvironment subtypes and neutrophil heterogeneity	36352227	10.1038/s41586-022-05400-x
ecm_myCAF	2020	Cancer Discovery	Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer	32434947	10.1158/2159-8290.CD-19-1384
detox_iCAF	2020	Cancer Discovery	Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer	32434947	10.1158/2159-8290.CD-19-1384
IL_iCAF	2020	Cancer Discovery	Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer	32434947	10.1158/2159-8290.CD-19-1384
TGFβ_myCAF	2020	Cancer Discovery	Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer	32434947	10.1158/2159-8290.CD-19-1384
wound_myCAF	2020	Cancer Discovery	Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer	32434947	10.1158/2159-8290.CD-19-1384
IFNγ_iCAF	2020	Cancer Discovery	Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer	32434947	10.1158/2159-8290.CD-19-1384
CAF_S1	2020	Cancer Discovery	Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer	32434947	10.1158/2159-8290.CD-19-1384
Normal_Fibroblast	2020	Cancer Discovery	Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer	32434947	10.1158/2159-8290.CD-19-1384
